A collaboration providing each patient with outstanding, personalized care

Welcome to Lankenau Heart Group, part of the Lankenau Heart Institute—a nationally recognized, world-class program that is at the forefront of cardiovascular medicine. Our group includes experienced board certified physicians, nurses and staff who collaborate to provide each patient with outstanding, personalized care. Our team of cardiologists, cardiovascular surgeons and sub-specialists offer uncompromising care at convenient locations throughout the Philadelphia area, including Lankenau Medical Center (home to our state-of-the-art Heart Pavilion), Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital, as well as many community offices across the region.

Services include:

  • General cardiology
  • Interventional cardiology
  • Electrophysiology
  • Heart failure
  • Cardiac surgery
  • Aortic surgery

Scheduling an appointment

Our office hours vary by physician and location. Please see find our location in your neighborhood and schedule your appointment. You may also request an appointment online.

  • After hours answering service available seven days a week
  • Telemedicine services available
  • For times when you may require care outside of our operating hours, we offer access to urgent care services seven days a week and holidays

Insurance

We accept most insurance plans, including HMOs and PPOs.

Awards

Check. Change. Control. Cholesterol Participant 2021 Seal

Check. Change. Control. Cholesterol™ Participant

Lankenau Heart Group has received the American Heart Association's Check. Change. Control. Cholesterol™ Participant status. This award acknowledges the group's commitment to reducing the risk of heart disease and stroke through improved cholesterol management. It also recognizes practices that have committed to improving ASCVD risk assessment and submitted data on appropriate statin therapy.

 Target: Type 2 Diabetes Gold Seal 2021

TARGET: Type 2 Diabetes Gold Award

Lankenau Heart Group has received the American Heart Association's Target: Type 2 Diabetes Gold award for implementing quality improvement measures addressing the relationship between diabetes and cardiovascular disease in outpatient settings. The Gold award recognizes practices that have fulfilled the Participant criteria AND have met the gold level thresholds for each of two selected clinical measures related to diabetes control and CVD risk factors, hypertension and high cholesterol.

TARGET: BP™ Recognition Gold Award

TARGET: BP™ Recognition Gold Award

Lankenau Heart Group has received the American Heart Association's Target: Type 2 Diabetes Gold award for implementing quality improvement measures addressing the relationship between diabetes and cardiovascular disease in outpatient settings. The Gold award recognizes practices that have fulfilled the Participant criteria AND have met the gold level thresholds for each of two selected clinical measures related to diabetes control and CVD risk factors, hypertension and high cholesterol. Lankenau Heart Group has been recognized by the American Heart Association (AHA) and American Medical Association (AMA) for their commitment to helping improve blood pressure (BP) control rates among the patient populations they serve, earning Gold level recognition as part of the 2021 Target: BP™ Recognition Program. The Gold award recognizes practices that have 70 percent or more of their adult patient population with high BP controlled.